Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?

The prognosis of invasive cervical cancer (CC) remains poor, with a treatment approach that has remained the same for several decades. Lately, a better understanding of the interactions between the disease and the host immune system has allowed researchers to focus on the employment of immune therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Turinetto, Margherita, Valsecchi, Anna A., Tuninetti, Valentina, Scotto, Giulia, Borella, Fulvio, Valabrega, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999051/
https://www.ncbi.nlm.nih.gov/pubmed/35408919
http://dx.doi.org/10.3390/ijms23073559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999051/
https://www.ncbi.nlm.nih.gov/pubmed/35408919
http://dx.doi.org/10.3390/ijms23073559

Ejemplares similares